- Home
- ANGH vs CCEL Comparison
ANGH vs CCEL Comparison
Compare ANGH & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANGH
- CCEL
- Stock Information
- Founded
- ANGH 2012
- CCEL 1989
- Country
- ANGH United Arab Emirates
- CCEL United States
- Employees
- ANGH N/A
- CCEL N/A
- Industry
- ANGH Telecommunications Equipment
- CCEL Managed Health Care
- Sector
- ANGH Consumer Discretionary
- CCEL Health Care
- Exchange
- ANGH Nasdaq
- CCEL Nasdaq
- Market Cap
- ANGH 47.5M
- CCEL 51.9M
- IPO Year
- ANGH N/A
- CCEL 1997
- Fundamental
- Price
- ANGH $0.55
- CCEL $5.05
- Analyst Decision
- ANGH
- CCEL Strong Buy
- Analyst Count
- ANGH 0
- CCEL 1
- Target Price
- ANGH N/A
- CCEL $8.50
- AVG Volume (30 Days)
- ANGH 8.9K
- CCEL 9.9K
- Earning Date
- ANGH 06-30-2025
- CCEL 04-15-2025
- Dividend Yield
- ANGH N/A
- CCEL 4.96%
- EPS Growth
- ANGH N/A
- CCEL N/A
- EPS
- ANGH N/A
- CCEL 0.01
- Revenue
- ANGH $78,093,405.00
- CCEL $32,102,750.00
- Revenue This Year
- ANGH N/A
- CCEL $2.49
- Revenue Next Year
- ANGH N/A
- CCEL $0.95
- P/E Ratio
- ANGH N/A
- CCEL $558.76
- Revenue Growth
- ANGH 88.72
- CCEL 2.33
- 52 Week Low
- ANGH $0.42
- CCEL $4.75
- 52 Week High
- ANGH $1.15
- CCEL $9.50
- Technical
- Relative Strength Index (RSI)
- ANGH 42.39
- CCEL 38.04
- Support Level
- ANGH $0.42
- CCEL $4.80
- Resistance Level
- ANGH $0.65
- CCEL $5.10
- Average True Range (ATR)
- ANGH 0.06
- CCEL 0.29
- MACD
- ANGH -0.00
- CCEL -0.00
- Stochastic Oscillator
- ANGH 55.75
- CCEL 25.00
About ANGH Anghami Inc.
Anghami Inc is a digital music entertainment technology platform in the Middle East and North Africa, with the catalog of songs. The company features licensed content from Arabic labels, independent artists, and distributors. It also features music from International labels such as Universal, Sony, and Warner and is continuously licensing new content.
About CCEL Cryo-Cell International Inc.
Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The Public cord blood banking segment consists of cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.